Tenax Therapeutics Statistics
Total Valuation
TENX has a market cap or net worth of $230.18 million. The enterprise value is $135.62 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, before market open.
Earnings Date | Mar 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TENX has 35.85 million shares outstanding. The number of shares has increased by 1,276.92% in one year.
Current Share Class | 3.97M |
Shares Outstanding | 35.85M |
Shares Change (YoY) | +1,276.92% |
Shares Change (QoQ) | -83.83% |
Owned by Insiders (%) | 0.02% |
Owned by Institutions (%) | 4.86% |
Float | 35.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.24 |
P/TBV Ratio | 2.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.60
Current Ratio | 20.60 |
Quick Ratio | 20.21 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -847.57 |
Financial Efficiency
Return on equity (ROE) is -35.17% and return on invested capital (ROIC) is -24.22%.
Return on Equity (ROE) | -35.17% |
Return on Assets (ROA) | -22.49% |
Return on Invested Capital (ROIC) | -24.22% |
Return on Capital Employed (ROCE) | -21.19% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.93M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.53% in the last 52 weeks. The beta is 2.19, so TENX's price volatility has been higher than the market average.
Beta (5Y) | 2.19 |
52-Week Price Change | +49.53% |
50-Day Moving Average | 6.42 |
200-Day Moving Average | 4.84 |
Relative Strength Index (RSI) | 50.16 |
Average Volume (20 Days) | 43,831 |
Short Selling Information
The latest short interest is 373,494, so 1.04% of the outstanding shares have been sold short.
Short Interest | 373,494 |
Short Previous Month | 381,701 |
Short % of Shares Out | 1.04% |
Short % of Float | 1.04% |
Short Ratio (days to cover) | 8.55 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -19.49M |
Pretax Income | -10.10M |
Net Income | -17.60M |
EBITDA | -19.49M |
EBIT | -19.49M |
Earnings Per Share (EPS) | -$5.15 |
Full Income Statement Balance Sheet
The company has $94.85 million in cash and n/a in debt, giving a net cash position of $94.85 million or $2.65 per share.
Cash & Cash Equivalents | 94.85M |
Total Debt | n/a |
Net Cash | 94.85M |
Net Cash Per Share | $2.65 |
Equity (Book Value) | 91.99M |
Book Value Per Share | 26.89 |
Working Capital | 91.99M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -14.81M |
Capital Expenditures | n/a |
Free Cash Flow | -14.81M |
FCF Per Share | -$0.41 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TENX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,276.92% |
Shareholder Yield | -1,276.92% |
Earnings Yield | -7.64% |
FCF Yield | -6.43% |
Analyst Forecast
The average price target for TENX is $16.00, which is 149.22% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $16.00 |
Price Target Difference | 149.22% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 3, 2024. It was a reverse split with a ratio of 0.0125:1.
Last Split Date | Jan 3, 2024 |
Split Type | Reverse |
Split Ratio | 0.0125:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |